Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
lisette koeneman
Boehringer Ingelheim, Germany
Poster(s):
(092) Comparing Healthcare Utilization and Cost in Empagliflozin vs GLP-1RA Initiators with Type 2 Diabetes without Established Cardiovascular Disease
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
